comparemela.com

Latest Breaking News On - Altium capital management - Page 2 : comparemela.com

Panbela Therapeutics, Inc. (NASDAQ:PBLA) Sees Large Decrease in Short Interest

Panbela Therapeutics, Inc. (NASDAQ:PBLA – Get Free Report) saw a significant drop in short interest during the month of November. As of November 15th, there was short interest totalling 64,900 shares, a drop of 22.2% from the October 31st total of 83,400 shares. Currently, 1.3% of the company’s shares are short sold. Based on an […]

Goldman-sachs-group-inc
Vanguard-group-inc
Panbela-therapeutics-inc
Nasdaq
Panbela-therapeutics-company-profile
Panbela-therapeutics
Get-free-report
Funds-management
Altium-capital-management
Panbela-therapeutics-daily
Nasdaq-pbla

Karyopharm Therapeutics (NASDAQ:KPTI) Price Target Lowered to $3.00 at Royal Bank of Canada

Karyopharm Therapeutics (NASDAQ:KPTI – Free Report) had its price target cut by Royal Bank of Canada from $4.00 to $3.00 in a report published on Friday morning, Benzinga reports. They currently have an outperform rating on the stock. Several other equities analysts have also commented on the company. Wedbush reiterated a neutral rating and issued […]

Canada
Arizona
United-states
Banque-cantonale-vaudoise
Gareng-bohlin
Piper-sandler
Karyopharm-therapeutics-inc
Royal-bank
Fund-management-co
Morgan-stanley
Kennedy-investment-group
Selective-inhibitor-of-nuclear-export

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Short Interest Up 10.6% in September

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Short Interest Up 10.6% in September
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Canada
Arizona
United-states
Banque-cantonale-vaudoise
Gareng-bohlin
Piper-sandler
Karyopharm-therapeutics-company-profile
Fund-management-co
Morgan-stanley
Selective-inhibitor-of-nuclear-export
Securities-exchange-commission
Royal-bank

Panbela Therapeutics, Inc. (NASDAQ:PBLA) Short Interest Down 18.2% in September

Panbela Therapeutics, Inc. (NASDAQ:PBLA – Get Free Report) saw a large decline in short interest in September. As of September 30th, there was short interest totalling 86,700 shares, a decline of 18.2% from the September 15th total of 106,000 shares. Based on an average daily trading volume, of 847,400 shares, the short-interest ratio is presently […]

Vanguard-group-inc
Panbela-therapeutics-inc
Nasdaq
Panbela-therapeutics
Get-free-report
Therapeutics-stock-down
Funds-management
Altium-capital-management
Panbela-therapeutics-daily
Nasdaq-pbla
Apbla

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Short Interest Update

Avadel Pharmaceuticals plc (NASDAQ:AVDL – Get Free Report) was the recipient of a significant growth in short interest during the month of September. As of September 15th, there was short interest totalling 3,340,000 shares, a growth of 28.0% from the August 31st total of 2,610,000 shares. Based on an average trading volume of 669,400 shares, […]

United-states
America
Piper-sandler
Craig-hallum
Thomass-mchugh
Samsara-biocapital
Perceptive-advisors
News-ratings-for-avadel-pharmaceuticals-daily
America-corp
Avadel-pharmaceuticals
Needham-company
Unisuper-management-pty-ltd

vimarsana © 2020. All Rights Reserved.